Journal article
In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation.
- Abstract:
-
BACKGROUND: We have investigated a novel nonmyeloablative conditioning regimen in 44 patients with hematological malignancies. The median patient age was 41 years. Many of the patients had high-risk features, including 19 patients with a previous failed transplant. METHODS: Recipient conditioning consisted of CAMPATH-1H 20 mg/day on Days -8 to -4, fludarabine 30 mg/m(2) on Days -7 to -3 and melphalan 140 mg/m(2) on Day -2. Thirty-six recipients received unmanipulated G-CSF mobilized PBSC fro...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- Cytotherapy
- Volume:
- 3
- Issue:
- 3
- Pages:
- 197-201
- Publication date:
- 2001-01-01
- DOI:
- EISSN:
-
1477-2566
- ISSN:
-
1465-3249
- Source identifiers:
-
13644
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:13644
- UUID:
-
uuid:96d5b37c-2d66-4249-9132-70d1ef58791b
- Local pid:
- pubs:13644
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 2001
If you are the owner of this record, you can report an update to it here: Report update to this record